Spinosad Suspension
Product Images NDC 84635-570

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Spinosad (NDC 84635-570). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipher Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Spinosad 01)

Chemical Structure (Spinosad 01)
Chemical structure of spinosad, the active ingredient in the topical suspension formulation labeled under Spinosad, 9 mg/mL by Cipher Pharmaceuticals Inc.*
FDA Label Image

Chemical Structure (Spinosad 02)

Chemical Structure (Spinosad 02)
Chemical structure of spinosad, the active ingredient in Spinosad topical suspension, 9 mg/mL by Cipher Pharmaceuticals Inc. The molecular diagram shows rings, oxygen, methyl groups, and nitrogen atoms characteristic of the compound.*
FDA Label Image

Image (Spinosad 03)

Image (Spinosad 03)
An instructional illustration showing a hand holding a bottle upright with arrows indicating a shaking motion moving the bottle up and down, demonstrating how to shake a suspension bottle before use.*
FDA Label Image

Image (Spinosad 04)

Image (Spinosad 04)
An instructional illustration showing a person with long hair applying a topical solution to the scalp using a dropper. One hand parts the hair while the other hand holds the dropper above the scalp, dispensing the medication.*
FDA Label Image

Image (Spinosad 05)

Image (Spinosad 05)
An instructional illustration depicting a person with eyes closed while two hands hold a cloth or pad over the eyes, and another hand gently holding the head. A bottle, possibly a medication or hygiene product, is visible beside the person's head shown in profile.*
FDA Label Image

Image (Spinosad 06)

Image (Spinosad 06)
An illustration showing a person applying liquid onto the scalp with one hand while the other hand holds a clock depicting a 10-minute wait. The text 'Wait 10 Minutes' is displayed, indicating a topical application wait time instruction.*
FDA Label Image

Image (Spinosad 07)

Image (Spinosad 07)
An instructional illustration showing a person applying a topical suspension to the scalp of another individual. One hand holds a container dispensing the liquid, while the other supports the head, demonstrating the application method for a topical suspension such as Spinosad 9 mg/mL.*
FDA Label Image

Image (Spinosad 08)

Image (Spinosad 08)
An instructional illustration depicting a hand holding a bottle or container and performing a shaking motion with arrows indicating movement up and down. This suggests shaking the bottle before use, associated with the topical suspension Spinosad 9 mg/mL by Cipher Pharmaceuticals Inc.*
FDA Label Image

Figure A (Spinosad 09)

Figure A (Spinosad 09)
Illustration showing a hand holding a forearm with an arrow indicating movement up and down along the lower arm near the wrist, likely demonstrating an application or motion technique for a topical suspension like Spinosad 9 mg/mL.*
FDA Label Image

Figure B (Spinosad 10)

Figure B (Spinosad 10)
An illustration showing the front and back views of a human figure in gray with an arrow indicating a length from the shoulder to mid-upper leg on the back view, suggesting a measurement or area of coverage.*
FDA Label Image

Figure C (Spinosad 11)

Figure C (Spinosad 11)
An anatomical illustration showing front and back views of a human figure with highlighted areas on the body, including parts of the arms, torso, knees, and groin region. This figure appears to indicate specific body locations, likely related to topical application guidance.*
FDA Label Image

Figure D (Spinosad 12)

Figure D (Spinosad 12)
An illustration showing a human figure alongside a stopwatch graphic indicating 10 minutes. The stopwatch is partially shaded to represent this time duration, likely indicating a timing or application instruction related to the drug.*
FDA Label Image

Figure E (Spinosad 13)

Figure E (Spinosad 13)
Illustration showing a figure dressed in long-sleeve pajamas alongside a clock icon indicating a 6-hour time interval. The image likely represents a recommended time period related to application or use of a topical product.*
FDA Label Image

Figure F (Spinosad 14)

Figure F (Spinosad 14)
An instructional illustration showing a human silhouette with water spraying from a showerhead onto the upper body area, likely demonstrating a rinsing or washing step related to topical application.*
FDA Label Image

Principal Display Panel (120 mL Bottle Carton)

Principal Display Panel (120 mL Bottle Carton)
The image shows the outer carton label for Spinosad topical suspension 0.9% w/w, a 120 mL topical suspension by Cipher Pharmaceuticals Inc. The packaging includes the product name, strength, route, and volume along with warnings, directions for use, storage instructions, and a barcode. The label features a red and gray color scheme with clear indication it is Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.